NFE2L2 and Alzheimer disease: Both in the SH-SY5Y cell model and the Aβ1-42-induced AD mouse model, it was verified that GO-Dau regulated the Nrf2/Keap1 anti-oxidative pathway and had a better effect on AD compared with GO or Dau alone.